Gujarathi Rahul, Candula Narsimha, Chippa Venu, Kadakia Meet, Alkhasawneh Ahmad
Hospital Medicine, University of Florida Health, Jacksonville, USA.
internal Medicine, St Vincent Medical Center, Evansville, USA.
Cureus. 2022 Jul 12;14(7):e26794. doi: 10.7759/cureus.26794. eCollection 2022 Jul.
Primary effusion lymphoma (PEL) is a rare form of high-grade non-Hodgkin's lymphoma that usually occurs in patients with compromised immunity or human immunodeficiency virus (HIV) infection. PEL is a B-cell lymphoma that principally presents as effusions without a tumor mass. We present a case of a 56-year-old African-American male with a medical history of HIV admitted to the hospital with right lung lower lobe pneumonia and parapneumonic effusion. Thoracentesis and pleural fluid cytology led to the diagnosis of PEL. He received treatment with chemotherapy and antiretroviral therapy (ART). The emphasis is to investigate immunocompromised patients presenting with pleural effusion for PEL, as it is a rare ailment with a high mortality rate.
原发性渗出性淋巴瘤(PEL)是一种罕见的高级别非霍奇金淋巴瘤,通常发生在免疫功能受损或感染人类免疫缺陷病毒(HIV)的患者中。PEL是一种B细胞淋巴瘤,主要表现为渗出液而无肿瘤肿块。我们报告一例56岁非裔美国男性病例,该患者有HIV病史,因右肺下叶肺炎和肺炎旁胸腔积液入院。胸腔穿刺术和胸水细胞学检查确诊为PEL。他接受了化疗和抗逆转录病毒疗法(ART)治疗。重点是对出现胸腔积液的免疫功能低下患者进行PEL调查,因为它是一种罕见且死亡率高的疾病。